4/17/2013 11:29:27 AM
MOUNTAIN VIEW, Calif., April 16, 2013 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. (Nasdaq:CCXI) announced today that it has priced an underwritten public offering of an aggregate of 5,000,000 shares of its common stock at a price to the public of $12.00 per share. In addition, ChemoCentryx has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock on the same terms and conditions to cover over-allotments, if any. All shares of common stock to be sold in the offering will be offered by ChemoCentryx.
comments powered by